# Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London
- Published: 2026-11-12
- Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md)
- Topics: [News](https://healthcarenews.io/news.md)
- Source: https://healthcarenews.io/news/enovis-to-present-at-the-annual-jefferies-global-healthcare-concerence-in-london/
- Publication: Healthcare News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://healthcarenews.io/editorial-policy/
Dallas, TX, Nov. 12, 2026 [(GLOBE NEWSWIRE)](https://www.globenewswire.com) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced that members of the Enovis management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 11:30 a.m. GMT (6:30 a.m. ET).
A link to the live audio webcast, as well as a replay of the event, will be available on the Company’s website under the Investors tab at Events and Presentations.
**About Enovis**
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com and follow us on Facebook, Instagram, LinkedIn and X.
**Investor Contact**
Kyle Rose, Vice President, Investor Relations
investorrelations@enovis.com
**Media Contact**
Rachel Colloff, Sr. Director, Corporate Communications
Rachel.Colloff@enovis.com
## Related
- [Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates](https://healthcarenews.io/news/serina-therapeutics-reports-third-quarter-2026-financial-results-and-provides-business-upd.md)
- [Crescent Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights](https://healthcarenews.io/news/crescent-biopharma-reports-third-quarter-2026-financial-results-and-recent-business-highli.md)
- [Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares](https://healthcarenews.io/news/prime-medicine-announces-closing-of-public-offering-and-full-exercise-of-the-underwriters.md)
- [YD Bio Announces FDA Grant of INTERACT Meeting Request for YDB-LMSCEV-001, an Investigational Extracellular Vesicle Candidate for Dry Eye Disease](https://healthcarenews.io/news/yd-bio-announces-fda-grant-of-interact-meeting-request-for-ydb-lmscev-001-an-investigation.md)